NIAID Banner Logo Image

Mycobacterium Citations List: June, 2018

Literature Citations

1. Synthesis and Biological Evaluation of 2-Aminothiazole-thiazolidinone Conjugates as Potential Antitubercular Agents. Abo-Ashour, M.F., W.M. Eldehna, R.F. George, M.M. Abdel-Aziz, M.M. Elaasser, S.M. Abou-Seri, and N.M. Abdel Gawad. Future Medicinal Chemistry, 2018. 10(12): p. 1405-1419. PMID[29788758].
[PubMed]. TB_06_2018.

2. Protein Binding of First-line Antituberculosis Drugs. Alghamdi, W.A., M.H. Al-Shaer, and C.A. Peloquin. Antimicrobial Agents and Chemotherapy, 2018. 62(7): e00641-00618. PMID[29735566]. PMCID[PMC6021678].
[PubMed]. TB_06_2018.

3. Synthesis of New C-Dimethylated chalcones as Potent Antitubercular Agents. Anandam, R., S.S. Jadav, V.B. Ala, M.J. Ahsan, and H.B. Bollikolla. Medicinal Chemistry Research, 2018. 27(6): p. 1690-1704. ISI[000432703900011].
[WOS]. TB_06_2018.

4. Synthesis and Biological Evaluation of Aryl-oxadiazoles as Inhibitors of Mycobacterium Tuberculosis. Angeles Martinez-Grau, M., I.C.G. Valcarcel, J.V. Early, R.K. Gessner, C.S. de Melo, E.M. Martin de la Nava, A. Korkegian, Y. Ovechkina, L. Flint, A. Gravelle, J.W. Cramer, P.V. Desai, L.J. Street, J. Odingo, T. Masquelin, K. Chibale, and T. Parish. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1758-1764. PMID[29680666].
[PubMed]. TB_06_2018.

5. 1,2,3-Triazole-fused spirochromenes as Potential Anti-tubercular Agents: Synthesis and Biological Evaluation. Ashok, D., P. Chiranjeevi, A.V. Kumar, M. Sarasija, V.S. Krishna, D. Sriram, and S. Balasubramanian. RSC Advances, 2018. 8(30): p. 16997-17007. ISI[000431814500064].
[WOS]. TB_06_2018.

6. Microwave-assisted Synthesis and Biological Evaluation of Thiazole-substituted dibenzofurans. Baba, N.H.K., D. Ashok, B.A. Rao, S. Madderla, and N.Y.S. Murthy. Heterocyclic Communications, 2018. 24(3): p. 171-176. ISI[000434385300010].
[WOS]. TB_06_2018.

7. Phenolic acid-tethered Isoniazid for Abrogation of Drug-induced Hepatotoxicity: Design, Synthesis, Kinetics and Pharmacological Evaluation. Bhilare, N.V., S.S. Dhaneshwar, and K.R. Mahadik. Drug Delivery and Translational Research, 2018. 8(3): p. 770-779. PMID[29498003].
[PubMed]. TB_06_2018.

8. Microwave-assisted ZrSiO2 Catalysed Synthesis, Characterization and Computational Study of Novel spiro[Indole-thiazolidines] Derivatives as Anti-tubercular Agents. Borad, M.A., M.N. Bhoi, S.K. Rathwa, M.S. Vasava, H.D. Patel, C.N. Patel, H.A. Pandya, E.A. Pithawala, and J.J. Georrge. Interdisciplinary Sciences, Computational Life Sciences, 2018. 10(2): p. 411-418. PMID[27837427].
[PubMed]. TB_06_2018.

9. Peniisocoumarins A-J: Isocoumarins from Penicillium Commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. Cai, R., Y. Wu, S. Chen, H. Cui, Z. Liu, C. Li, and Z. She. Journal of Natural Products, 2018. 81(6): p. 1376-1383. PMID[29792702].
[PubMed]. TB_06_2018.

10. Mycelial Growth and Antimicrobial Activity of Pleurotus Species (Agaricomycetes). Castillo, T.A., R.A. Lemos, J.R.G. Pereira, J.M.A. Alves, and M.F.S. Teixeira. International Journal of Medicinal Mushrooms, 2018. 20(2): p. 191-200. PMID[29773010].
[PubMed]. TB_06_2018.

11. Expanding Benzoxazole-based Inosine 5'-monophosphate dehydrogenase (IMPDH) Inhibitor Structure-activity as Potential Antituberculosis Agents. Chacko, S., H.I.M. Boshoff, V. Singh, D.M. Ferraris, D.R. Gollapalli, M. Zhang, A.P. Lawson, M.J. Pepi, A. Joachimiak, M. Rizzi, V. Mizrahi, G.D. Cuny, and L. Hedstrom. Journal of Medicinal Chemistry, 2018. 61(11): p. 4739-4756. PMID[29746130].
[PubMed]. TB_06_2018.

12. Three New Platinum Complexes Containing Fluoroquinolones and DMSO: Cytotoxicity and Evaluation against Drug-resistant Tuberculosis. de Oliveira, L.P., Z.A. Carneiro, C.M. Ribeiro, M.F. Lima, D.A. Paixao, M. Pivatto, M.V.N. de Souza, L.R. Teixeira, C.D. Lopes, S. de Albuquerque, F.R. Pavan, and W. Guerra. Journal of Inorganic Biochemistry, 2018. 183: p. 77-83. PMID[29567518].
[PubMed]. TB_06_2018.

13. Heteronuclear 5-Fluoroisatin Dimers: Design, Synthesis, and Evaluation of Their in Vitro Anti-mycobacterial Activities. Deng, J.-L., X.-C. Liu, G.-W. Cai, G. Zhang, L. Hu, L. Qiu, Z.-Y. Li, and Z. Xu. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1509-1513. ISI[000435277300030].
[WOS]. TB_06_2018.

14. Evaluation of Octyl-beta-D-glucopyranoside (OGP) for Cytotoxic, Hemolytic, Thrombolytic, and Antibacterial Activity. Dinesh, M., S. Deepika, R. HarishKumar, C.I. Selvaraj, and S.M. Roopan. Applied Biochemistry and Biotechnology, 2018. 185(2): p. 450-463. PMID[29178056].
[PubMed]. TB_06_2018.

15. Synthesis of Avibactam Derivatives and Activity on beta-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria. Edoo, Z., L. Iannazzo, F. Compain, I. Li de la Sierra Gallay, H. van Tilbeurgh, M. Fonvielle, F. Bouchet, E. Le Run, J.L. Mainardi, M. Arthur, M. Etheve-Quelquejeu, and J.E. Hugonnet. Chemistry, 2018. 24(32): p. 8081-8086. PMID[29601108].
[PubMed]. TB_06_2018.

16. Design, Synthesis and in Vitro Antitubercular Evaluation of Isatin-Ciprofloxacin Hybrids with Hydrogen Bonding Capacity. Fan, Y.-L., M. Liu, F.-z. Zhang, and S. Zhang. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1494-1498. ISI[000435277300027].
[WOS]. TB_06_2018.

17. Synthesis of Ethylene Tethered Isatin-Coumarin Hybrids and Evaluation of Their in Vitro Antimycobacterial Activities. Gao, T., Z. Zeng, G. Wang, S. Sun, and Y. Liu. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1484-1488. ISI[000435277300025].
[WOS]. TB_06_2018.

18. Design, Synthesis, and in Vitro Anti-mycobacterial Activities of Propylene-tethered Heteronuclear bis-Isatin Derivatives. Hua, X., G. Zhang, D. Zhang, and Y. Wu. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1504-1508. ISI[000435277300029].|
[WOS]. TB_06_2018.

19. The Discovery of an Iridium(III) Dimer Complex as a Potent Antibacterial Agent against Non-replicating Mycobacterium smegmatis. Liao, G., X. Peng, T. Li, Z. Ye, X. Xiang, and C. Fu. Polymers, 2018. 10(3): 10030297. ISI[000428388200071].
[WOS]. TB_06_2018.

20. In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China. Luo, J., X. Yu, G. Jiang, Y. Fu, F. Huo, Y. Ma, F. Wang, Y. Shang, Q. Liang, Y. Xue, and H. Huang. Antimicrobial Agents and Chemotherapy, 2018. 62(7): e00072-00018. PMID[29760127]. PMCID[PMC6021646].
[PubMed]. TB_06_2018.

21. Synthesis and Biological Evaluation of Aryl-oxadiazoles as Inhibitors of Mycobacterium tuberculosis. Martinez-Grau, M.A., I.C.G. Valcarcel, J.V. Early, R.K. Gessner, C.S. de Melo, E.M.M. de la Nava, A. Korkegian, Y. Ovechkina, L. Flint, A. Gravelle, J.W. Cramer, P.V. Desai, L.J. Street, J. Odingo, T. Masquelin, K. Chibale, and T. Parish. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1758-1764. PMID[29680666]. PMCID[PMC5946847].
[PubMed]. TB_06_2018.

22. 2-Mercapto-quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization. Murugesan, D., P.C. Ray, T. Bayliss, G.A. Prosser, J.R. Harrison, K. Green, C. Soares de Melo, T.S. Feng, L.J. Street, K. Chibale, D.F. Warner, V. Mizrahi, O. Epemolu, P. Scullion, L. Ellis, J. Riley, Y. Shishikura, L. Ferguson, M. Osuna-Cabello, K.D. Read, S.R. Green, D.A. Lamprecht, P.M. Finin, A.J.C. Steyn, T.R. Ioerger, J. Sacchettini, K.Y. Rhee, K. Arora, C.E. Barry, 3rd, P.G. Wyatt, and H.I.M. Boshoff. ACS Infectious Diseases, 2018. 4(6): p. 954-969. PMID[29522317]. PMCID[PMC5996347].
[PubMed]. TB_06_2018.

23. Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics. Nasrin, S., S. Ganji, K.S. Kakirde, M.R. Jacob, M. Wang, R.R. Ravu, P.A. Cobine, I.A. Khan, C.C. Wu, D.A. Mead, X.C. Li, and M.R. Liles. Journal of Natural Products, 2018. 81(6): p. 1321-1332. PMID[29897754].
[PubMed]. TB_06_2018.

24. Potent 1,2,4-Triazino[5,6 b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis. Ngo, H.X., K.D. Green, C.S. Gajadeera, M.J. Willby, S.Y.L. Holbrook, C. Hou, A. Garzan, A.S. Mayhoub, J.E. Posey, O.V. Tsodikov, and S. Garneau-Tsodikova. ACS Infectious Diseases, 2018. 4(6): p. 1030-1040. PMID[29601176].
[PubMed]. TB_06_2018.

25. Antimycobacterial Activity of Nitrogen Heterocycles Derivatives: 7-(Pyridine-4-yl)-indolizine Derivatives. Part VII8-12. Olaru, A.-M., V. Vasilache, R. Danac, and I.I. Mangalagiu. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 32(1): p. 1291-1298. PMID[29072097].
[PubMed]. TB_06_2018.

26. Anti-Mycobacterium tuberculosis Activity of Esters of Quinoxaline 1,4-di-N-oxide. Palos, I., J. Luna-Herrera, E.E. Lara-Ramirez, A. Loera-Piedra, E. Fernandez-Ramirez, M.G. Aguilera-Arreola, A.D. Paz-Gonzalez, A. Monge, B. Wan, S. Franzblau, and G. Rivera. Molecules, 2018. 23(6): E1453. PMID[29914062].
[PubMed]. TB_06_2018.

27. Extracts of Ansellia africana and Platycarpha glomerata Exhibit Antibacterial Activities against Some Respiratory Tract, Skin and Soft Tissue Infections Implicated Bacteria. Penduka, D., W. Mthembu, K.H. Cele, R.A. Mosa, A.M. Zobolo, and A.R. Opoku. South African Journal of Botany, 2018. 116: p. 116-122. ISI[000432546500015].
[WOS]. TB_06_2018.

28. New Chromane-based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies. Pini, E., G. Poli, T. Tuccinardi, L.R. Chiarelli, M. Mori, A. Gelain, L. Costantino, S. Villa, F. Meneghetti, and D. Barlocco. Molecules, 2018. 23(7): E1506. PMID[29933627].
[PubMed]. TB_06_2018.

29. Hit Discovery of Mycobacterium tuberculosis Inosine 5'-monophosphate dehydrogenase, GuaB2, Inhibitors. Sahu, N.U., V. Singh, D.M. Ferraris, M. Rizzi, and P.S. Kharkar. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1714-1718. PMID[29699922].
[PubMed]. TB_06_2018.

30. Growth Medium-dependent Antimicrobial Activity of Early Stage MEP Pathway Inhibitors. Sanders, S., D. Bartee, M.J. Harrison, P.D. Phillips, A.T. Koppisch, and C.L.F. Meyers. Plos One, 2018. 13(5): e0197638. PMID[29771999]. PMCID[PMC5957436].
[PubMed]. TB_06_2018.

31. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Schmidt, U., G. Theumer, A. Jager, O. Kataeva, B. Wan, S.G. Franzblau, and H.J. Knolker. Molecules, 2018. 23(6): E1402. PMID[29890747].
[PubMed]. TB_06_2018.

32. Structure-based Screening and Molecular Dynamics Simulations Offer Novel Natural Compounds as Potential Inhibitors of Mycobacterium tuberculosis Isocitrate lyase. Shukla, R., H. Shukla, A. Sonkar, T. Pandey, and T. Tripathi. Journal of Biomolecular Structure & Dynamics, 2018. 36(8): p. 2045-2057. PMID[28605994].
[PubMed]. TB_06_2018.

33. Identification of Cyclic Hexapeptides Natural Products with Inhibitory Potency against Mycobacterium tuberculosis. Singh, S.B., J. Odingo, M.A. Bailey, B. Sunde, A. Korkegian, T. O'Malley, Y. Ovechkina, T.R. Ioerger, J.C. Sacchettini, K. Young, D.B. Olsen, and T. Parish. BMC Research Notes, 2018. 11(1): p. 416. PMID[29954459].
[PubMed]. TB_06_2018.

34. Design, Synthesis, and Evaluation of Novel N-1 Fluoroquinolone Derivatives: Probing for Binding Contact with the Active Site Tyrosine of Gyrase. Towle, T.R., C.A. Kulkarni, L.M. Oppegard, B.P. Williams, T.A. Picha, H. Hiasa, and R.J. Kerns. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1903-1910. PMID[29661533]. PMCID[PMC5938125].
[PubMed]. TB_06_2018.

35. Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals. Xiong, L., C. Gao, Y.J. Shi, X. Tao, C.T. Peng, J. Rong, K.L. Liu, Q. Lei, Y.W. Zhang, N.Y. Wang, and L.T. Yu. Antimicrobial Agents and Chemotherapy, 2018. 62(7): e02375-02317. PMID[29686156]. PMCID[PMC6021648].
[PubMed]. TB_06_2018.

36. 4-Thiazolidinone Coumarin Derivatives as Two-component NS2B/NS3 DENV Flavivirus Serine Protease Inhibitors: Synthesis, Molecular Docking, Biological Evaluation and Structure-Activity Relationship Studies. Yusufzai, S.K., H. Osman, M.S. Khan, B.M. Abd Razik, M.O. Ezzat, S. Mohamad, O. Sulaiman, J.A. Gansau, and T. Parumasivam. Chemistry Central Journal, 2018. 12(1): p. 69. PMID[29896651]. PMCID[PMC5997609].
[PubMed]. TB_06_2018.

37. Design, Synthesis and Biological Activity of Pyrazinamide Derivatives for anti-Mycobacterium tuberculosis. Zhou, S., S. Yang, and G. Huang. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 32(1): p. 1183-1186. PMID[28870094].
[PubMed]. TB_06_2018.

Patent Citations

38. Novel Compounds as Anti-mycobacterials. Payne, R.J., W.J. Britton, A. Tran, and W. Tran. Patent. 2018. 2017-AU51394 2018107236: 226pp.
[Patent]. TB_06_2018.

Database last updated: September 2018